Lianbio-ADRLIANY

13F holders, Q1 2024 (March 31)
3holders
$0.32avg. 13F price*

At the end of Q1 2024, 3 institutions reported holding Lianbio-ADR (LIANY) in their 13F filings. The largest holders were Rhumbline Advisers ($41K), Goldman Sachs Group Inc. ($5K) and FNY Investment Advisers, LLC ($4K).

Company
Lianbio-ADR
CUSIP
53000N108
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q1 2024: 3Q1 2024Q2 2024: 2Q2 2024Q3 2024: 2Q3 2024Q4 2024: 2Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions3$49K
Exits30$377.3M

Ownership 3 holders

Rhumbline Advisers 0.00% New 125,457 $41K
Goldman Sachs Group Inc. 0.00% New 14,621 $5K
FNY Investment Advisers, LLC 0.00% New 13,800 $4K

"% of holder's portfolio" is LIANY's weight in each manager's 13F, not the share of Lianbio-ADR the manager owns.